
Stevan A Gonzalez MD
Hepatology & Liver Transplantation
Medical Director of Liver Transplantation
Join to view full profile
1250 8th AveSte 515Fort Worth, TX 76104
Phone+1 817-922-4675
Fax+1 817-922-4645
Dr. Gonzalez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stevan Gonzalez is a Fort Worth-based gastroenterologist with subspecialties in hepatology and liver transplantation. He completed his medical education at Geisel School of Medicine at Dartmouth and furthered his training in internal medicine and gastroenterology at New York Presbyterian Hospital, followed by a transplant hepatology fellowship at Stanford Health Care. Since 2008, he has served as the Medical Director of Baylor Scott & White All Saints Medical Center and practices with Baylor Scott & White HealthTexas Provider Network. His clinical expertise includes managing conditions such as primary biliary cirrhosis, hepatitis B, and liver diseases like NAFLD and ALD. Dr. Gonzalez has contributed to several publications in the field and is involved in clinical trials focusing on treatments for hepatorenal syndrome. He has received CMS Meaningful Use certifications in recognition of his contributions to healthcare information technology.
Education & Training
Stanford Health CareFellowship, Transplant Hepatology, 2007 - 2008
Columbia Mailman School of Public HealthMS, Biostatistics, 2005 - 2007
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2004 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2000 - 2003
Geisel School of Medicine at DartmouthClass of 2000
Certifications & Licensure
TX State Medical License 2008 - 2027
CA State Medical License 2007 - 2008
NY State Medical License 2002 - 2007
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012, 2014-2015, 2017
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2012, 2014-2015, 2017
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
Publications & Presentations
PubMed
- MASLD risk factors: searching beyond the metabolic syndrome.Sameera N Shuaibi, Stevan A Gonzalez
Proceedings. 2026-09-29 - Endoscopic ultrasound-guided liver biopsy: refining a new approach.Theresa A Reno, Stevan A Gonzalez
Proceedings. 2026-09-01 - 2 citationsThe management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices.Giuseppe Cullaro, Gene Y Im, Shaun Chandna, Brian T Lee, Douglas A Simonetto
Hepatology Communications. 2026-04-01
Journal Articles
- INFUSE: Rationale and Design of a Multi-Center, Open Label, Collaborative Study to Treat HRS-AKI with Continuous Terlipressin Infusion.Weinberg E, Rahematpura S, Gonzalez SA, Izzy MJ, Simonetto DA, Frederick RT, Rubin RA, Ikahihifo-Bender J, Harte, M, Kim-Lee G, Witkiewicz S, Tobin W, Jamil K, Fricker..., Contemporary Clinical Trials Communications
- Terlipressin versus Midodrine plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.Gonzalez SA, Chirikov VV, Wang WJ, Huang X, Jamil K, Simonetto DA., Clinical and Translational Gastroenterology
- A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal DysfunctionBernard Fischbach, James F Trotter, W R Kim, Stevan A Gonzalez, Goran Klintmalm, Sumeet K Asrani, Michael Emmett, Ranjeeta Bahirwani, Josh Levitsky, Mitra K Nadim, Hepatology
Press Mentions
Smartphone App to Assess Stool Form, Rural-Urban Disparities in Cirrhosis Mortality, Lung Infection Risk in Severe Alcoholic Hepatitis in July Issue of AJGJuly 5th, 2022- COMMENTARY: COVID Collaboration: Working Group Demonstrates Potential for InnovationMarch 19th, 2021
Professional Memberships
- Member
- American Association for the Study of Liver Disease - AASLDMember
- American Society of Transplantation - ASTMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: